SAN DIEGO (AP) _ Tracon Pharmaceuticals Inc. (TCON) on Tuesday reported a loss of $6.3 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 45 cents.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 45 cents per share.
The antibody drug developer posted revenue of $617,000 in the period.
For the year, the company reported that its loss widened to $27 million, or $2.13 per share. Revenue was reported as $3.4 million.
In the final minutes of trading on Tuesday, the company's shares hit $3.90. A year ago, they were trading at $6.64.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCON at https://www.zacks.com/ap/TCON
Keywords: Tracon Pharmaceuticals, Earnings Report